Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19

被引：35
|
作者：
Giovannoni, Gavin [1 ]
机构：
[1] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 41卷
关键词：
OCRELIZUMAB;
D O I：
10.1016/j.msard.2020.102135
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case series
    Stascheit, Frauke
    Ruebsam, Anne
    Otto, Carolin
    Meisel, Andreas
    Ruprecht, Klemens
    Pleyer, Uwe
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (10) : 3028 - 3038
  • [42] Anti-CD20 monoclonal antibody (mAb) therapy and colitis: A case series and review
    Tolaymat, Sarah
    Sharma, Kanika
    Kagzi, Yusuf
    Sriwastava, Shitiz
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 75
  • [43] Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
    Pardo, Gabriel
    Pineda, Elmor D.
    Ng, Carmen D.
    Bawa, Komal K.
    Sheinson, Daniel
    Bonine, Nicole G.
    NEUROLOGY AND THERAPY, 2022, 11 (01) : 337 - 351
  • [44] Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
    Gabriel Pardo
    Elmor D. Pineda
    Carmen D. Ng
    Komal K. Bawa
    Daniel Sheinson
    Nicole G. Bonine
    Neurology and Therapy, 2022, 11 : 337 - 351
  • [45] Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis
    Sriwastava, Shitiz
    Kataria, Saurabh
    Srivastava, Samiksha
    Kazemlou, Shaghayegh
    Gao, Si
    Wen, Sijin
    Saber, Hamidreza
    Tripathi, Richa
    Sheikh, Zubeda
    Peterson, Sarah
    Gwinn, Ronald
    Bernitsas, Evanthia
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 360
  • [46] Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
    Samjoo, Imtiaz A.
    Worthington, Evelyn
    Drudge, Christopher
    Zhao, Melody
    Cameron, Chris
    Haering, Dieter A.
    Stoneman, Dee
    Klotz, Luisa
    Adlard, Nicholas
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (18) : 1255 - 1274
  • [47] Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies
    Zivadinov, Robert
    Keenan, Alexander J.
    Le, Hoa H.
    Ait-Tihyaty, Maria
    Gandhi, Kavita
    Zierhut, Matthew L.
    Salvo-Halloran, Elizabeth M.
    Ramirez, Abril Oliva
    Vuong, Vivian
    Singh, Sumeet
    Hutton, Brian
    BMC NEUROLOGY, 2024, 24 (01)
  • [48] Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy
    Freeman, S. A.
    Zephir, H.
    REVUE NEUROLOGIQUE, 2024, 180 (10) : 1047 - 1058
  • [49] Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
    Shinodaa, Koji
    Lia, Rui
    Rezk, Ayman
    Mexhitaj, Ina
    Patterson, Kristina R.
    Kakara, Mihir
    Zuroff, Leah
    Bennett, Jeffrey L.
    von Buedingen, H. -Christian
    Carruthers, Robert
    Edwards, Keith R.
    Fallis, Robert
    Giacomini, Paul S.
    Greenberg, Benjamin M.
    Hafler, David A.
    Ionete, Carolina
    Kaunzner, Ulrike W.
    Lock, Christopher B.
    Longbrake, Erin E.
    Pardo, Gabriel
    Piehl, Fredrik
    Weber, Martin S.
    Ziemssen, Tjalf
    Jacobs, Dina
    Gelfand, Jeffrey M.
    Cross, Anne H.
    Cameron, Briana
    Musch, Bruno
    Winge, Ryan C.
    Jia, Xiaoming
    Harp, Christopher T.
    Herman, Ann
    Bar-Ora, Amit
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (03)
  • [50] New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come
    Nicholas, J.
    Morgan-Followell, B.
    Pitt, D.
    Racke, M. K.
    Boster, A.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2012, 4 : 81 - 103
12345